Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin

Alok Pant, Irene I. Lee, Zhenxiao Lu, Bo R. Rueda, Julian Schink, J. Julie Kim

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin'. Together they form a unique fingerprint.

INIS

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience